The Serratia marcescens serine protease, which is directed by the gene encoding a precursor composed of a typical NH2-terminal signal sequence, a mature enzyme domain, and a large COOH-terminal domain, was excreted through the outer membrane ofEscherichia coli. The precursor, with the expected molecular size (110 kilodaltons), was detected in an insoluble form in the periplasmic space of E. coli cells after induction with isopropyl-13-D-thiogalactopyranoside of the expression of the gene under the control of the tac promoter. Upon membrane fractionation of the disrupted cells by sucrose density gradient centrifugation, the precursor was recovered from a fraction slightly heavier than the outer membrane fraction but not from the inner membrane fraction. Conversion of the precursor into the mature form, which was accompanied by its excretion into the medium, was observed even in the absence of de novo protein synthesis caused by the addition of chloramphenicol. The mutated gene product lacking all of the COOH-terminal domain was localized in the periplasmic space only and was not excreted into the medium. Additional mutant genes were generated by site-directed mutagenesis to test the role of some amino acids in the excretion of this protease in E. coli. The mutant protein with no protease activity because of the change of the catalytic residue Ser-341 to Thr was still excreted into the medium but with abnormal processing. Both self-processing and host-dependent processing of the precursor seem to be involved in the excretion of the mature enzyme. Replacement of the four Cys residues, two in the mature enzyme and two in the COOH-terminal domain, with Ser in different combinations caused a distinct or complete loss of excretion, suggesting that a certain conformation possibly formed via disulfide bonding was important for the excretion of the S. marcescens protease.
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It is well known that Escherichia coli, a gram-negative bacterium, has two distinct membrane systems, the outer membrane and the inner cytoplasmic membrane. Several enzymes of E. coli, such as alkaline phosphatase and Plactamase, contain NH2-terminal signal sequences; during their export through the inner membrane into the periplasmic space, the signal sequences are processed by a leader peptidase(s) (2, 13, 14, 21, 27) . In such cases, the outer membrane functions as a barrier to prevent further secretion into the extracellular medium. However, it has also been noted that several gram-negative bacteria possess the ability to secrete extracellular enzymes directly into the medium without cell lysis (12, 26) . Even in E. coli, hemolysin is excreted through the outer membrane with the aid of other proteins but without any lysis of cells (7) (8) (9) .
Recently, we cloned the gene of Serratia marcescens serine protease (SSP), one of the extracellular enzymes of this gram-negative bacterium, into E. coli; SSP was excreted in a specific manner through the outer membrane of the host (28) . The nucleotide sequence of the cloned SSP gene, together with a determination of the NH2 and COOH termini of the excreted enzyme, suggested that this protease is produced as a 112-kilodalton (kDa) preproenzyme and that its NH2-terminal signal peptide and large COOH-terminal domain are processed during its export through the inner membrane and the outer membrane, respectively. We also found that the introduction of out-of-frame mutations, even in the coding region for the COOH-terminal domain, resulted in no secretion of SSP. These results indicate that the primary translation product consists of three functional domains, i.e., an NH2-terminal signal peptide (Met-1 to Ala-27) probably required for export through the inner membrane, the mature protease (Ala-28 to Asp-408), and a large COOH-terminal domain (Ile-409 to Phe-1045) apparently required for extracellular secretion. Specific excretion from E. coli was also observed with the cloned gene for the Neisseria gonorrhoeae immunoglobulin A protease, which possesses a construction somewhat similar to that of SSP (23) .
In the present study, we detected the SSP precursor, which is presumably associated with the outer membrane, and confirmed the conversion of the precursor to the mature enzyme along with its excretion by an immunological method. We also constructed several mutations by oligonucleotide-directed mutagenesis to determine the roles of several residues in the precursor in the excretion of SSP.
MATERIALS AND METHODS
Bacterial strains and plasmids. E. coli JM105 [A(lac pro) thi rpsL endA sbcB15 hsdR4 F' traD36 proAB lacd lacZAM15], purchased from Amersham Co. Ltd., was used as the host for both phage M13 propagation and expression of SSP. Plasmid pSP11 (28) , containing the SSP gene on pBR322 (25) , was from E. coli C600 (hsdR hsdM leu thr thi supE). Plasmid pCR906, which had been constructed for the purpose of expression of prochymosin in this laboratory, was used as a source of the tac promoter (6) . M13 phage (3, 000 Ci/ mmol) were purchased from Amersham. General techniques, including isolation of plasmid DNA by CsCl-ethidium bromide ultracentrifugation and by the rapid isolation method, agarose gel electrophoresis, recovery of DNA from agarose gel slices, and transformation of E. coli were described previously (18) .
Antibody preparation. Mature SSP was purified from the supernatant of E. coli C600 containing pSP11 as described previously (28) . About 0.5 mg of purified SSP was mixed with 0.5 ml of complete Freund adjuvant and injected into a male albino rabbit intradermally at multiple sites. A booster injection of 0.5 mg of SSP in 0.5 ml of incomplete Freund adjuvant was given 1 month later at the same sites. Three weeks after the booster injection, whole serum was prepared by a standard method and fractionated with ammonium sulfate up to 20 to 35% saturation.
Western blot (immunoblot) hybridization. Western blot hybridization was performed by the method of Burnett (3) with the above-described anti-SSP antibody. Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis was performed by the method of Laemmli (17) .
Conversion of the precursor to mature SSP in the presence of chloramphenicol. Ten milliliters of an overnight culture of E. coli JM105 harboring pSPlltac was inoculated in 100 ml of L broth (20) containing 50 jig of ampicillin per ml. After further incubation at 37°C for 4 h, 1 mM isopropyl-p-Dthiogalactopyranoside (IPTG) was added to induce the tac promoter and incubated at 37°C for an additional 2 h. The cells were harvested by centrifugation at 5,000 x g for 5 min and washed twice with fresh L broth containing 100 ,ug of chloramphenicol per ml. The washed cells were suspended in 100 ml of L broth containing 100 jig of chloramphenicol and 50 ,ug of ampicillin per ml and incubated aerobically at 37°C. Ten milliliters of this culture was removed at intervals. Each sample was fractionated, and the extracellular and insoluble fractions were analyzed by SDS-polyacrylamide gel electrophoresis and Western blot hybridization. Molecular markers used were phosphorylase b (94 kDa), bovine serum albumin (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), trypsin inhibitor (20 kDa), and RNase A (14 kDa Trypsin treatment. Harvested E. coli cells were subjected to the same cold osmotic shock as that described above. Trypsin (Sigma Chemical Co.) was added to the shocked cells to a final concentration of 0.1 mg/ml, and the mixture was incubated at 37°C for 30 min. The reaction was stopped by the addition of trypsin inhibitor (from soybeans; Sigma) at a concentration of 0.2 mg/ml, and the mixture was placed on ice for 15 min. The cells were fractionated for subsequent analysis.
Membrane fractionation. Membranes were fractionated by the method of Miura and Mizushima (22) by sucrose density gradient centrifugation. E. coli containing pSPlltac grown in 100 ml of L broth as described above was centrifuged at 6,000 x g for 5 min at 4°C and washed twice with buffer B containing 50 mM Tris hydrochloride (pH 7.5), 250 mM sucrose, and 1 mM dithiothreitol. The washed cells were suspended in buffer B (5 ml/l g of wet cells) containing 10 ,ug of DNase I per ml and disrupted with a French press at 8,000 lb/in2. Cell debris was removed by low-speed centrifugation at 2,500 x g for 10 min at 4°C, and the membranes were collected by high-speed centrifugation of the supernatant at 155,000 x g for 2 h at 4°C. The membranes obtained in this way were suspended in 1 ml of 10 mM Tris hydrochloride (pH 7.8) and fractionated by 20 to 53% (wt/wt) sucrose density gradient centrifugation at 70,000 x g for 12 were synthesized on a System 1 Plus DNA synthesizer (Beckman Instruments, Inc.) by the phosphoamidate method and purified by 20% polyacrylamide gel electrophoresis. Table 1 lists their sequences with the corresponding mutated positions. Appropriate restriction fragments containing the sites to be mutated were subcloned into the polylinker of phage M13mp19. This fragment was subjected to oligonucleotide-directed mutagenesis by the gapped-duplex method (15) . Mutant progenies were selected by plaque hybridization with, as probes, the mutagenic primers labeled at the 5' end with 32P (19) . Mutated sites were checked by nucleotide sequencing by the M13 dideoxynucleotide method (24) . After preparation of the replicative form, the mutant DNA fragments obtained by digestion with the respective restriction enzymes were transferred to the original plasmid, pSPlltac. The construction of each mutant plasmid obtained in this way was checked by restriction mapping. SSP in the extracellular fraction prepared from E. 
RESULTS
Detection of the SSP precursor. For expression of a large amount of SSP in E. coli cells, the SSP gene was inserted downstream of the tac promoter, which is known to be one of the strongest promoters in E. coli (Fig. 1 ). E. coli JM105 harboring plasmid pSPlltac obtained in this way was incubated, and the tac promoter was induced by IPTG. We fractionated the E. coli cells to detect the precursor of SSP by Western blot hybridization. Mature SSP with an apparent molecular mass of 58 kDa was found in the extracellular fraction (Fig. 2) . The calculated molecular mass of the extracellular protein is 43 kDa. We assume that the difference in molecular size was caused by an abnormal mobility of the protein on the SDS-polyacrylamide gel. In the insoluble fraction, a protein band with a mass of 110 kDa and reacting positively with the anti-SSP antibody was found.
To determine whether the 110-kDa protein detected as described above was a native secreted intermediate, we examined the conversion of the precursor to the mature form. E. coli cells harboring pSPlltac induced with IPTG were washed to remove the excreted mature enzyme and suspended in fresh medium containing chloramphenicol to avoid de novo synthesis of protein. Even in the presence of 100 ,ug of chloramphenicol per ml, the 58-kDa SSP in the medium gradually increased and the 110-kPa protein in the insoluble fraction gradually decreased (Fig. 3A) . The amount of SSP excreted was comparable to that of the precursor released. These results showed that the 110-kDa protein, the precursor of SSP possibly lacking its NH2-terminal signal peptide (Met-1 to Ala-27), was the native secreted intermediate and not an inactive intermediate like an inclusion body. Localization of the precursor. When the induced cells accumulating the precursor were fractionated into the periplasmic, insoluble, and particulate fractions by the cold osmotic shock treatment, all of the precursor protein was detected in the insoluble fraction by immunoblotting and SDS-polyacrylamide gel electrophoresis (Fig. 2) . To localize the insoluble precursor, we treated the cells with trypsin after the cold osmotic shock treatment, making the outer membrane permeable for large molecules (5) . The data in Fig. 3B clearly show that the precursor in the insoluble fraction was completely digested by trypsin. These findings strongly suggested that the precursor was localized in an insoluble form in the periplasm.
These data also suggested the possibility that the precursor in the periplasm was associated with the inner or outer membrane. We therefore performed membrane fractionation by sucrose density gradient centrifugation to determine with which membrane the precursor was associated. The distribution of the outer membrane proteins and NADH dehydrogenase activity in each fraction showed that the fractionation of both membranes was successfully carried out (data not shown). The precursor was detected in a fraction slightly heavier than that of the outer membrane but not at all in a fraction corresponding to the inner cytoplasmic membrane (Fig. 4) .
Necessity of the COOH-terminal domain for extracellular excretion but not for secretion through the inner membrane. The 110-kDa precursor was found to be the true intermediate, and its large COOH-terminal domain was therefore processed during excretion through the outer membrane. We next examined whether the COOH-terminal domain was . . . . . . . . . . . . . . . . . . . . . . . required for excretion by using plasmid pSPRV3tac, which encoded the protein lacking the COOH-terminal domain. Plasmid pSPRV3tac was constructed (as shown in Fig. 1 ) such that a Gln codon and a TGA stop codon were inserted at the processing site between Asp-408 and Ile-409. No protease activity or mature enzyme was detected in the culture medium of E. coli JM105 containing pSPRV3tac. Instead, a protein reacting positively with the anti-SSP antibody was detected only in the insoluble fraction (Fig. 5) . Furthermore, as in the case of the intact precursor protein, the immunoactive protein was also found in a fraction slightly heavier than the main fraction of the outer membrane when cells were fractionated by the method described above (Fig. 6 ). These findings suggested that the COOHterminal domain was absolutely required for extracellular excretion but not for translocation through the inner membrane. The immunoactive protein specified by pSPRV3tac was slightly smaller than mature SSP, being 58 kDa in size (see below).
Site-directed mutagenesis. We next generated six mutant genes by site-directed mutagenesis to examine the roles of several residues or regions in the precursor protein in the excretion of SSP (Table 2) . Table 2 also summarizes extracellular protease activities directed by these mutant genes. Western blot analysis of the extracellular fractions is shown in Fig. 7A . A schematic representation of the mutated sites is shown in Fig. 7B .
(i) Catalytic residue Ser-341. The residue Ser-341 in the mature enzyme is assumed to be one of the residues forming the triad catalytic center of serine protease (16) . In pSP121, Ser-341 was replaced by Thr to inactivate the enzyme. The mutant plasmid failed to produce protease activity in the medium, as expected. However, this mutant plasmid still caused excretion of a protein that cross-reacted with the antibody and that had a molecular mass slightly higher than that of the native mature enzyme (Fig. 7) . This finding suggested that the processing of the COOH-terminal domain is self-catalyzed by its own proteolytic activity but that a certain protease of the E. coli host cell plays an alternative role in processing and excretion. Fig. 7 . b ND, Not detected.
(ii) COOH terminus. We observed that deletion of the eight amino acids at the COOH-terminal end of the primary translation product led to the loss of the extracellular protease activity (28) . The COOH-terminal region was thus important for excretion. This observation prompted us to construct pSP151, in which a positively charged amino acid, Arg-1044, was replaced by a negatively charged amino acid, Asp. However, the mutant protein was normally processed, and the mature protease was normally excreted.
(iii) Glu-701 in an a-helix. In pSP131, Glu-701, possibly located in an a-helix in the COOH-terminal domain, as predicted by computer analysis (4), was changed to an a-helix breaker, Pro. The mutant enzyme was apparently processed normally, although the mutation caused slight decreases in both extracellular protease activity and excretion of the cross-reacting protein.
(iv) Putative disulfide bonds. The nucleotide sequence revealed that the precursor contained four Cys residues; two were in the mature protein, and the other two were in the COOH-terminal domain. On the assumption that a certain specific conformation formed via disulfide bonding between these Cys residues affects the excretion efficiency, we changed these Cys residues to Ser. One of the plasmids was pSP161M, in which the two Cys residues in the mature protein were replaced by Ser. E. coli JM105 containing pSP161M excreted a mature protein with protease activity, but at a slightly lower level than in the case of the nonmutated plasmid, pSP101. The data in the mutations caused no decrease in the specific activity. In pSP161P, the two Cys residues in the COOH-terminal domain were changed to Ser. Excretion of the mature enzyme slightly decreased, as observed with pSP161M. On the other hand, changing all the Cys residues to Ser (pSP161MP) caused a complete loss of the protease activity and the protein cross-reacting with the anti-SSP antibody in the medium. In the insoluble fraction, however, we detected a 110-kDa precursor (data not shown).
DISCUSSION
The present work clearly confirms our previous model on the excretion of SSP from E. coli cells (28); i.e., the enzyme is first exported into the periplasm as the 110-kDa precursor, and then the mature enzyme is excreted through the outer membrane, during which its large COOH-terminal domain is processed. Although the precursor was detected in the particulate fraction after cell disruption, it was digested by trypsin treatment of the osmotically shocked cells. Almost quantitative conversion of the precursor into the mature form was also observed in the presence of chloramphenicol.
These results indicate that the precursor is present in the periplasm as a functional intermediate in the SSP secretion pathway.
On membrane fractionation by sucrose density gradient centrifugation, the precursor was detected in fractions slightly heavier than the main fraction of the outer membrane but not in the inner membrane fraction. In addition, the mutant protein lacking the entire COOH-terminal domain was also detected in exactly the same fraction. If the fraction corresponds to a complex of the native SSP precursor or its mutant with the outer membrane, the COOHterminal domain might not be involved in the association. However, the present data do not exclude the possibility that in the excretion of native SSP the COOH-terminal domain itself is also associated with the outer membrane. Further analyses of the putative complex with the outer membrane are required to solve this problem.
Notwithstanding these ambiguous observations on the interaction of the precursor with the outer membrane, it is obvious that the COOH-terminal domain plays an essential role in the export of SSP through the outer membrane. Concerning the excretion of the N. gonorrhoeae immunoglobulin A protease, Pohlner et al. (23) assumed that the characteristic hydrophilic region in the COOH-terminal domain ("helper") forms a pore structure in the outer membrane to facilitate the export of the mature enzyme. Although such hydrophilic regions have been found in the COOH-terminal domain of SSP by computer analysis (11), VOL. 171, 1989 on November 6, 2017 by guest http://jb.asm.org/ Downloaded from site-directed mutagenesis revealed functional roles of several sites.
The replacement of Ser-341, one of the catalytic residues of protease activity, with Thr caused the excretion of the two distinct antibody-cross-reacting proteins slightly larger than the native mature enzyme. This result indicates that processing of the precursor at the native site is due to its own proteolytic activity but that a certain protease of the E. coli host plays an alternative role in excretion by processing the precursor at some sites in the COOH-terminal domain.
Changing Arg-1044 at the penultimate position of the precursor to Asp failed to inactivate excretion. This result excludes the role of the precursor as an anchor associating with the outer membrane, a possibility which had been assumed on the basis of our previous observation (28) . Eleven a-helices are predicted in the COOH-terminal domain of the SSP precursor by Chou-Fassman analysis (4); seven of them cluster in the central region, but the destruction of one of them by changing Glu-701 to Pro had no effect on excretion. On the other hand, changing four Cys residues, two in the mature enzyme and two in the COOH-terminal domain, caused complete inactivation, indicating a requirement for a specific conformation of the precursor for excretion of the mature protein. Additional mutants are required to elucidate the correlation between the conformation of the precursor and the excretion of the mature enzyme.
An additional note we would like to mention is that the immunoactive protein specified by pSPRV3tac is slightly smaller, by about 10 kDa, than mature SSP when examined by SDS-polyacrylamide gel electrophoresis. Although this difference may have been caused by an additional Gln residue which was generated as a result of the DNA manipulation, it is also conceivable that the primary processing site in the SSP precursor is located closer to the COOH-terminal end than previously thought (Asp-408 to Ile-409) by analysis of the COOH-terminal amino acids (28) . The data in this paper, however, are still valid and useful for elucidating the mechanism of SSP excretion. We are now trying to elucidate the mechanism of processing of the precursor during excretion.
